Adamas Pharmaceuticals, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$14.6M
Doctors Paid
4,478
Transactions
31,516
2021 Total
$1.1M
Payment Breakdown by Category
Research$10.6M (72.4%)
Food & Beverage$507,291 (3.5%)
Travel$334,001 (2.3%)
Consulting$124,055 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $10.6M | 3,350 | 72.4% |
| Honoraria | $2.9M | 1,405 | 20.0% |
| Food and Beverage | $507,291 | 25,015 | 3.5% |
| Travel and Lodging | $334,001 | 1,108 | 2.3% |
| Grant | $124,913 | 52 | 0.9% |
| Consulting Fee | $124,055 | 20 | 0.9% |
| Education | $4,915 | 566 | 0.0% |
Payments by Type
Research
$10.6M
3,350 transactions
General
$4.0M
28,166 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A 3-ARM MULTICENTER DOUBLE-BLIND PLACEBO-CONTROLLED RANDOMIZED STUDY TO ASSESS THE EFFICACY AND SAFETY OF ADS-5102 AMANTADINE EXTENDED RELEASE CAPSULES IN MULTIPLE SCLEROSIS PATIENTS WITH WALKING IMPAIRMENT | $7.4M | 0 | 1,946 |
| A MULTICENTER OPEN-LABEL SAFETY AND EFFICACY STUDY OF ADS-5102 AMANTADINE EXTENDED RELEASE CAPSULES IN PATIENTS WITH MULTIPLE SCLEROSIS AND WALKING IMPAIRMENT | $2.8M | 0 | 1,343 |
| OPEN-LABEL SAFETY STUDY OF ADS-5102 AMANTADINE HCL EXTENDED RELEASE CAPSULES FOR THE TREATMENT OF LEVODOPA INDUCED DYSKINESIA | $368,831 | 0 | 58 |
| OPEN-LABEL SAFETY STUDY OF ADS-5102 (AMANTADINE HCL) EXTENDED RELEASE CAPSULES FOR THE TREATMENT OF LEVODOPA INDUCED DYSKINESIA | $6,463 | 0 | 1 |
| EFFICACY AND SAFETY OF ADS-5102 AMANTADINE HCL EXTENDED RELEASE CAPSULES FOR THE TREATMENT OF LEVODOPA INDUCED DYSKINESIA IN PARKINSONS DISEASE PATIENTS EASE LID STUDY | $5,840 | 0 | 2 |
Payments by Medical Specialty
Top Paid Doctors — Page 2
| Doctor | Specialty | Location | Total | 2021 |
|---|---|---|---|---|
| Sanjay Iyer, Md, MD | Neurology | Charlotte, NC | $34,857 | $0 |
| Dr. Martha Mcgraw, M.d, M.D | Neurology | Winfield, IL | $32,462 | $0 |
| Dr. Rajeev Kumar, Md, MD | Neurology | Englewood, CO | $32,056 | $0 |
| Mariana Varga, Md, MD | Neuromuscular Medicine | Oklahoma City, OK | $31,229 | $0 |
| Dr. Keith Hull, M.d, M.D | Neurology | Raleigh, NC | $31,109 | $0 |
| Dr. Eric Farbman, M.d, M.D | Neurology | Fresno, CA | $30,215 | $0 |
| Unknown Provider | — | — | $28,640 | $0 |
| Raja Mehanna, Md, MD | Neurology | Houston, TX | $27,252 | $0 |
| Dr. Fiona Gupta, M.d, M.D | Neurology | Oradell, NJ | $27,029 | $0 |
| Dr. Luisa Solis-Cohen, M.d, M.D | Student in an Organized Health Care Education/Training Program | Littleton, CO | $26,225 | $0 |
| Mark Lew, M.d, M.D | Neurology | Los Angeles, CA | $25,893 | $0 |
| Fernando Pagan | Neurology | Washington, DC | $24,199 | $0 |
| Mr. Danish Bhatti, Mbbs, MBBS | Neurology | Orlando, FL | $23,782 | $0 |
| Jerome Lisk, Md, MD | Neurology | Denton, TX | $23,767 | $0 |
| Dr. Barry Vaught, M.d, M.D | Neurology | Crab Orchard, WV | $23,647 | $0 |
| Dr. Aaron Miller, M.d, M.D | Neurology | New York, NY | $23,130 | $0 |
| Myla Goldman, Md, MD | Neurology | Richmond, VA | $23,009 | $0 |
| Dr. Daniel Mattson, Md, MD | Neurology | Bridgeton, MO | $22,842 | $0 |
| Madhavi Thomas, M.d, M.D | Neurology | Flower Mound, TX | $22,532 | $0 |
| William Ondo, M.d, M.D | Neurology | Houston, TX | $22,439 | $0 |
| John Wulff, Md, MD | Neurology | Muncie, IN | $22,025 | $0 |
| Rajesh Pahwa, M.d, M.D | Neurology | Kansas City, KS | $21,971 | $0 |
| Dr. Cheryl Waters, M.d, M.D | Neurology | New York, NY | $21,658 | $0 |
| Jeffrey Cohen, Md, MD | Neurology | Cleveland, OH | $20,100 | $0 |
| Dr. Michelle Cameron, Md, MD | Neurology | Portland, OR | $19,370 | $0 |
About Adamas Pharmaceuticals, Inc.
Adamas Pharmaceuticals, Inc. has made $14.6M in payments to 4,478 healthcare providers, recorded across 31,516 transactions in the CMS Open Payments database. In 2021, the company paid $1.1M. The top product by payment volume is GOCOVRI ($3.9M).
Payments were distributed across 116 medical specialties. The top specialty by payment amount is Neurology ($3.0M to 2,690 doctors).
Payment categories include: Food & Beverage ($507,291), Consulting ($124,055), Research ($10.6M), Travel & Lodging ($334,001).
Adamas Pharmaceuticals, Inc. is associated with 2 products in the CMS Open Payments database.